Aurobindo Pharma USA Inc. recalls Gabapentin Capsules, USP 100mg 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810
Recalled April 22, 2020 · FDA recall D-1232-2020 · Aurobindo Pharma USA
Hazard
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed · FDA Class II
Units
26625 units
Sold at
Nationwide within the United States
Description
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Product
Gabapentin Capsules, USP 100mg 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65862-198-99
Manufacturer(s)
Aurobindo Pharma USA Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →